ð é«åžçç
ð äžé éé»
3 Main Pathogenic Free-Living Amebae
1. Naegleria fowleri (âBrain-Eating Amebaâ)
- Primary Amebic Meningoencephalitis (PAM)
- Rapid fatal (mortality > 97%)
- Warm freshwater swimming (pools, lakes, hot springs, neti pot)
- Nasal entry â cribriform plate â olfactory bulbs â CNS
- Rare (< 10 USA cases/yr; ~ 200 cases known worldwide)
- 2024: climate change expanding range (more northern outbreaks)
2. Acanthamoeba spp.
- Granulomatous Amebic Encephalitis (GAE) â chronic, in immunocompromise + AIDS
- Acanthamoeba Keratitis â contact lens wearers, ocular
- Cutaneous Acanthamoebiasis
- Disseminated in immunocompromise
3. Balamuthia mandrillaris
- GAE â similar to Acanthamoeba but also in immunocompetent
- Subacute / chronic
- Cutaneous + CNS
- Rare globally
Naegleria fowleri (PAM)
Microbiology
- Thermophilic amoeba (37-45°C ideal)
- Trophozoite + flagellate (transient) + cyst forms
- Worldwide in warm freshwater
Transmission
- Diving / swimming in warm freshwater (lakes, hot springs, ponds, inadequately chlorinated pools)
- Nasal irrigation with contaminated water (neti pot use) â sentinel cases
- NOT person-to-person
Clinical (PAM)
- 1-9 day incubation
- Sudden onset:
- Severe headache (frontal)
- Fever
- Stiff neck
- Vomiting
- Olfactory disturbance / loss
- Progressive over 24-72 hr:
- Altered mental status
- Seizures
- Cranial nerve palsies
- Coma â death within 1-2 weeks
- Mortality > 97%
Diagnosis
- CSF examination: lymphocytic pleocytosis with some PMN, low glucose, high protein
- CSF microscopy (wet mount, Giemsa): trophozoites
- PCR of CSF + biopsy
- MRI: meningitis, hemorrhage, basal cisterns
Treatment
- Combination therapy (no proven single regimen):
- Amphotericin B IV + intrathecal (high-dose)
- Miltefosine PO (key drug, FDA accelerated 2013)
- Azithromycin, fluconazole, rifampin
- Dexamethasone
- Therapeutic hypothermia (rare survivor cases)
- < 10 documented survivors globally
- 2024 +: ongoing investigational protocols
Prevention
- Avoid swimming in warm freshwater during hot weather (Texas + Florida + Gulf states)
- Plug or hold nose during freshwater activities
- Use boiled / distilled water for neti pot / nasal irrigation
- Donât drink + donât reuse untreated water
Acanthamoeba
Geography + Sources
- Worldwide
- Soil, water, dust, air conditioning, contact lens cases
Diagnosis
- Keratitis: corneal scraping + Giemsa / calcofluor white + culture + PCR
- GAE: CSF + brain biopsy + PCR
- Skin: biopsy + PCR
Keratitis
- Topical antiamebic combination: chlorhexidine + polyhexamethylene biguanide (PHMB) + propamidine + neomycin
- Long course (months)
- Surgery (corneal transplant) for severe / refractory
GAE / Disseminated
- Miltefosine + combination (azole + sulfadiazine + macrolide + others)
- Immune restoration (ART for HIV)
- Mortality high
Balamuthia mandrillaris
Background
- Identified 1990 (Mandrill baboon brain)
- Worldwide soil + dust
- Causes GAE + cutaneous in immunocompetent + immunocompromise
Clinical
- Subacute / chronic GAE (weeks-months)
- Headache, focal signs, mass lesions
- Cutaneous lesions (often precede CNS)
- Mortality 89%+
Diagnosis
- Brain biopsy
- Skin biopsy
- PCR
Treatment
- Miltefosine + combination (fluconazole + azithromycin + clarithromycin + 5-flucytosine + albendazole + nitroxoline)
- Multi-drug; long course
Sappinia pedata + Diphylleia (Rare)
1ïžâ£ Naegleria fowleri (PAM) Detail
Microbiology
- Thermophilic free-living ameba
- 37-45°C ideal (warm freshwater)
- Trophozoite (motile invasive form), flagellate (swimming, transient), cyst (resistant)
- Worldwide distribution
Transmission Specifics
- Water enters nose (diving, swimming with head submerged)
- Cribriform plate of ethmoid bone â olfactory bulbs â CNS
- Neti pot outbreaks documented (use tap water with contamination)
- Inadequately chlorinated pools, hot springs, splash pads
- USA: Texas, Florida, Arizona + Gulf states; climate change expanding north
USA Cases
- 1-10 cases/yr
- Texas + Florida + Arizona + Louisiana most
- Children + young males predominant (recreational water activity)
- 2024+: northern cases (Minnesota, Indiana, Nebraska, etc.)
Clinical PAM (Primary Amebic Meningoencephalitis)
Acute Phase
- Sudden onset severe headache (often frontal)
- Fever
- Nausea / vomiting
- Olfactory disturbance / anosmia (key early clue)
- Stiff neck
Progressive Phase (24-72 Hours)
- Altered mental status
- Seizures
- Confusion â coma
- Cranial nerve palsies
- Photophobia
- Cardiovascular collapse
Outcome
- Death within 7-14 days of onset in > 97% of cases
- < 10 documented survivors worldwide (since 1962 first cases)
- Recent survivors (2013+, 2016+) â combination therapy + therapeutic hypothermia
Diagnosis
CSF
- Lymphocytic pleocytosis with significant PMN (initially can be very PMN-dominant)
- Low glucose (< 40 mg/dL often)
- High protein
- RBCs common (hemorrhagic)
- Opening pressure elevated
CSF Microscopy
- Wet mount of fresh CSF: motile trophozoites
- Giemsa stain: trophozoites
- Donât refrigerate before examination (kills trophozoites)
- Hemorrhagic CSF in many
PCR
- CSF + brain biopsy
- Most sensitive
- Reference labs (CDC)
Imaging
- MRI: basal cistern enhancement, meningitis, hemorrhage
- May be normal early
- Cerebral edema common
Differential
- Bacterial meningitis
- Viral encephalitis (HSV, others)
- Cryptococcal meningitis
- TB meningitis
Treatment (Combination)
- Amphotericin B IV (high-dose) + intrathecal (lifesaving combination)
- Miltefosine PO (FDA accelerated approval 2013; key oral agent)
- Azithromycin (combination)
- Fluconazole / voriconazole (combination)
- Rifampin (combination)
- Dexamethasone (steroid for edema)
- Therapeutic hypothermia (some survivor cases)
- ICU + ventilator + supportive
- CDC consultation 24/7 hotline for treatment guidance
Recent Survivors
- 2013 Texas case (Kali Hardig): combination Tx + hypothermia
- 2016 Florida case (Sebastian DeLeon): combination Tx + hypothermia
- 2018 Texas case
- 2024 ongoing cases
- Survival rate: < 3% overall, but increasing with awareness + new protocols
Prevention
- Avoid diving / underwater swimming in warm freshwater during hot weather
- Use nose clip or hold nose
- Neti pot: boiled or distilled water only (not tap water)
- Donât drink + irrigate eyes with untreated water
- Pool maintenance + chlorination
- Public health warnings
2ïžâ£ Acanthamoeba
Geography + Sources
- Worldwide in soil, water, dust, AC systems
- Contact lens cases + tap water = major exposure for keratitis
- Also: hot tubs, swimming pools, soil contact
Diagnosis
Keratitis
- Corneal scraping for:
- Giemsa / hematoxylin stain
- Calcofluor white (fluorescent stain) â cysts
- Culture on non-nutrient agar with E. coli lawn
- PCR
- Confocal microscopy
- High index of suspicion (often misdiagnosed as HSV initially)
GAE / Disseminated
- CSF microscopy / PCR
- Brain biopsy + PCR + IHC
- Skin biopsy
Treatment
Keratitis
- Topical combination antiamebic:
- Chlorhexidine 0.02% or polyhexamethylene biguanide (PHMB) 0.02% (cyst-killing)
- Propamidine 0.1% (Brolene) or hexamidine (trophozoite-killing)
- Neomycin (broad antibacterial)
- Long course (3-12 months)
- Topical steroid carefully (controversial; mostly avoided)
- Penetrating keratoplasty for refractory + visual impairment
- Visual outcomes variable; many require corneal transplant
GAE / Disseminated
- Miltefosine (oral)
- Combination: fluconazole + sulfadiazine + azithromycin / clarithromycin + flucytosine + pentamidine
- Long course
- Mortality high (90%+)
- ART for HIV
Prevention
- Contact lens hygiene:
- No tap water rinse
- Use sterile saline / proper solution
- No swimming with lens
- Donât extend wear time
- Sterile contact lens solution storage
- Avoid sleeping in lenses
3ïžâ£ Balamuthia mandrillaris
Background
- Identified 1990 (mandrill baboon brain)
- Worldwide soil + dust
- Particularly cases in immigrant Hispanic populations USA
- Soil contact + water exposure
Clinical
GAE
- Immunocompetent + immunocompromise (unlike Acanthamoeba)
- Subacute / chronic (weeks-months-years)
- Headache, seizures, focal neuro signs
- Mass lesions on MRI
- Brainstem + spinal involvement possible
Cutaneous
- Often precedes CNS (months-years)
- Painless skin lesion or plaque
- Face, knees, legs typical
- Slowly enlarging
- Can spread hematogenously to CNS
Disseminated
- Lungs, liver, etc.
- Multi-organ
Diagnosis
- Brain biopsy (often only definitive)
- Skin biopsy with PCR
- CSF rarely positive
- Slow culture
- PCR sensitivity emerging
Treatment
- Miltefosine + combination:
- Fluconazole
- Azithromycin / clarithromycin
- 5-flucytosine
- Albendazole
- Nitroxoline (emerging)
- Pentamidine sometimes
- Multi-drug long course (months)
- Mortality 89%+
- Earlier diagnosis improves outcome
4ïžâ£ Treatment Considerations
Miltefosine
- Key drug for all 3 free-living amebae (Naegleria, Acanthamoeba, Balamuthia)
- FDA accelerated approval 2013 for free-living amebae
- Available via CDC for compassionate use
- Mechanism: cell membrane disruption + apoptosis
- Toxicity: GI, hepatic, teratogenic (pregnancy contraindicated)
- Long half-life
CDC Consultation
- 24/7 hotline for suspected free-living ameba infections
- Treatment guidance
- Miltefosine acquisition
Survivors of PAM (Lessons)
- Aggressive combination therapy early
- Therapeutic hypothermia in some
- Targeted treatment as soon as suspected â donât wait for confirmation
- Public awareness + faster recognition